Linda C. Lambert

发表

Influenza vaccines for the future.

Anthony S. Fauci, A. Fauci, Linda C. Lambert, 2010, The New England journal of medicine.

Report on the second WHO integrated meeting on development and clinical trials of influenza vaccines that induce broadly protective and long-lasting immune responses: Geneva, Switzerland, 5-7 May 2014.

N. Cox, G. Rimmelzwaan, J. Hickling, 2015, Vaccine.

Safety and Immunogenicity of a Subvirion Monovalent Unadjuvanted Inactivated Influenza A(H3N2) Variant Vaccine in Healthy Persons ≥18 Years Old

M. Mulligan, W. Keitel, Shital M. Patel, 2015, The Journal of infectious diseases.

Pertussis vaccine trials in the 1990s.

Linda C. Lambert, 2014, The Journal of infectious diseases.

Improving influenza vaccine virus selection: report of a WHO informal consultation held at WHO headquarters, Geneva, Switzerland, 14–16 June 2010

Sarah Cobey, Neil Ferguson, Maria Zambon, 2013, Influenza and other respiratory viruses.

Evaluation of a single dose of half strength inactivated influenza vaccine in healthy adults.

Mark Wolff, W. Keitel, R. Belshe, 2002, Vaccine.

Current Concepts Influenza Vaccines for the Future

A. Fauci, Linda C. Lambert, 2010 .

Point-of-Use Mixing of Influenza H5N1 Vaccine and MF59 Adjuvant for Pandemic Vaccination Preparedness: Antibody Responses and Safety. A Phase 1 Clinical Trial

D. Bernstein, M. Mulligan, N. Rouphael, 2014, Open forum infectious diseases.

Improving influenza vaccine virus selectionReport of a WHO informal consultation held at WHO headquarters, Geneva, Switzerland, 14–16 June 2010

N. Ferguson, A. Monto, N. Cox, 2011, Influenza and other respiratory viruses.

Pertussis vaccine trials in the 1990s.

Linda C. Lambert, 2014, The Journal of infectious diseases.